68979-64-6Relevant academic research and scientific papers
PDE10 MODULATORS
-
Paragraph 0240, (2013/03/26)
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used in the treatment of CNS disorders such as schizophrenia, Alzheimer's disease, and Parkinson's disease.
PDE10 MODULATORS
-
Page/Page column 42, (2013/03/26)
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.
Aryl-substituted triazolyl propionic acids
-
, (2008/06/13)
Aryl-substituted-1,2,4-triazolyl propionic acid compounds, possessing antiinflammatory activity are disclosed. The compounds include: 3-[3-phenyl-1,2,4,(1H)-triazol-5-yl] propionic acid monohydrate; 3-[1-(3-chloro) phenyl and 3-[1-(3,5-dichloro)-phenyl-1,
